A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Kura Oncology, Inc.
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
Tel-Aviv Sourasky Medical Center
Xencor, Inc.
Nuvectis Pharma, Inc.
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
University of Nebraska
Kidney Cancer Research Bureau
Adela, Inc
Elephas
Elephas
University of Cambridge
Degron Therapeutics Co.
University Health Network, Toronto
Dana-Farber Cancer Institute
Massive Bio, Inc.
Hadassah Medical Organization
A2 Biotherapeutics Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Columbia University
Centre Georges Francois Leclerc
University Health Network, Toronto
Hospices Civils de Lyon
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Second Affiliated Hospital of Guangzhou Medical University
Shanghai Yunying Medical Technology
Hospices Civils de Lyon